120013-56-1

Basic information

• Product Name: 6-O-DESMETHYL DONEPEZIL
• Synonyms: 6-O-DESMETHYL DONEPEZIL;1-Benzyl-4-[(6-hydroxy-5-methoxy-1-oxo-indan-2-yl)methylpiperidine;2,3-Dihydro-6-hydroxy-5-Methoxy-2-[[1-(phenylMethyl)-4-piperidinyl]Methyl]-1H-inden-1-one;2-((1-benzylpiperidin-4-yl)methyl)-6-hydroxy-5-methoxy-2,3-dihydro-1H-inden-1-one
• CAS NO: 120013-56-1
• Molecular Formula: C₂₃H₂₇NO₃
• Molecular Weight: 365.47
• Product Categories: Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;Heterocycles;Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 120013-56-1.mol
• Article Data: 3

Chemical Properties

• Melting Point: 57-59°C
• Boiling Point: 545.3±50.0 °C(Predicted)
• Appearance: /
• Density: 1.190±0.06 g/cm3(Predicted)
• Storage Temp.: -20°C Freezer
• Solubility: Chloroform (Slightly), Dichloromethane, Methanol (Slightly)
• PKA: 9.46±0.40(Predicted)
• Stability: Temperature Sensitive
• CAS DataBase Reference: 6-O-DESMETHYL DONEPEZIL(CAS DataBase Reference)
• NIST Chemistry Reference: 6-O-DESMETHYL DONEPEZIL(120013-56-1)
• EPA Substance Registry System: 6-O-DESMETHYL DONEPEZIL(120013-56-1)

Safety Data

• Hazardous Substances Data: 120013-56-1(Hazardous Substances Data)

Usage

Chemical Properties

Pale Yellow Solid

Uses

Different sources of media describe the Uses of 120013-56-1 differently. You can refer to the following data:
1. A metabolite of Donepezil, an inhibitor of acetylcholinesterase
2. A metabolite of Donepezil (D531750), an inhibitor of acetylcholinesterase.

Upstream product

• 1135-24-6 3-(4-hydroxy-3-methoxyphenyl)acrylic acid 
• 1135-24-6 (E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid 
• 90843-62-2 6-hydroxy-5-methoxyindan-1-one 
• 1135-23-5 3-(4-hydroxy-3-methoxyphenyl)propionic acid 
• 120014-06-4 donepezil 

Downstream Products

• 571144-16-6 1-benzyl-4-[(6-ethoxy-5-methoxy-1-indanon)-2-yl]methylpiperidine 
• 1033718-50-1 tert-butyl 2-(2-((1-benzylpiperidin-4-yl)methyl)-6-methoxy-3-oxo-2,3-dihydro-1H-inden-5-yloxy)acetate 

Relevant articles and documents

Combining chalcones with donepezil to inhibit both cholinesterases and aβ fibril assembly

The fact that the number of people with Alzheimer's disease is increasing, combined with the limited availability of drugs for its treatment, emphasize the need for the development of novel effective therapeutics for treating this brain disorder. Herein, we focus on generating 12 chalcone-donepezil hybrids, with the goal of simultaneously targeting amyloid-β (Aβ) peptides as well as cholinesterases (i.e., acetylcholinesterase (AChE) and butyrylcholinesterase (BChE)). We present the design, synthesis, and biochemical evaluation of these two series of novel 1,3-chalcone-donepezil (15a-15f) or 1,4-chalcone-donepezil (16a-16f) hybrids. We evaluate the relationship between their structures and their ability to inhibit AChE/BChE activity as well as their ability to bind Aβ peptides. We show that several of these novel chalcone-donepezil hybrids can successfully inhibit AChE/BChE as well as the assembly of N-biotinylated Aβ(1-42) oligomers. We also demonstrate that the Aβ binding site of these hybrids differs from that of Pittsburgh Compound B (PIB).

Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

-